Recently, the domain name genesis.bio was sold for $30,000 through the Atom.com platform, becoming a typical case of domain name transactions in the biotechnology field due to its golden combination of “core vocabulary + industry suffix”.

The core value of this domain name stems from the high degree of compatibility between “genesis” and the .bio suffix. “Genesis” originates from Greek and means “origin, occurrence, generation,” possessing strong professional relevance in fields such as biology and medicine—it is commonly used to describe core scientific concepts such as cell generation and the origin of life, and is also a root component of professional terms such as “oogenesis” and “angiogenesis.” This inherently scientific vocabulary makes the domain name naturally suitable for high-end sectors such as biotechnology, pharmaceutical research and development, and gene technology.
Furthermore, the .bio suffix, as a targeted top-level suffix, further strengthens the industry focus. This domain extension is specifically designed for fields such as biology, organic industry, and health technology. It conveys the core meaning of “biological” and “organic” in languages across 52 countries worldwide, combining professionalism with international universality. It not only helps companies quickly establish industry recognition but also attracts a precise target audience. The high prices previously paid for domains like my.bio further demonstrate the market acceptance of this extension.
The combination of genessis.bio can be considered an “industry-brand-level domain”: “genesis” conveys the brand association of “origins of innovation and life sciences,” while the .bio extension clearly defines business boundaries, perfectly matching diverse scenarios such as biotechnology startups, gene research institutions, and organic product brands. For companies seeking a professional image and brand recognition, this type of domain, with its “precise meaning + suitable extension,” can significantly reduce communication costs while highlighting a core positioning of deep industry expertise.
This $30,000 sale price further confirms the value potential of domains in the biotechnology field. As global biotechnology continues to gain momentum, domain names that combine scientific meaning with industry-specific attributes are becoming increasingly scarce. The sale of genesis.bio provides an important reference for the market value of similar domain names.
The article comes from the Internet. If there is any infringement, please notify me to delete it. Please indicate the source when reprinting!
If you have news to publish, please send it to:article@domain.news
